Biotech Investors & VC Firms in Asia-Pacific
746 firms in this list, with a median first check of $500K. 161 of them lead rounds. Generated from verified public data and updated continuously.
Omron Ventures
KyotoSeed–Growth
2 people
Oriza Holdings
SuzhouSeed–Series C
2 people
Pivotal bioVenture Partners China
ShanghaiSeed–Series A
4 people
Company K Partners
SeoulSeries A–Series B
Advantech Capital
Camana BayGrowth
3 people
CAS Star
Xi’anPre-Seed–Growth
3 people
SL Investment Ltd.
SeoulSeries A–Late Stage$500K – $2M
Everlife
Singapore
1 person
Nan Fung Life Sciences
Hong KongSeed–Growth
1 person
Chang'an Capital
BeijingSeed–Series B
3 people
CBC Group
SingaporeSeed–Late Stage
2 people
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
East Gate Partners
SeoulSeed–Series A
2 people
Global Venture Capital, Inc.
TokyoSeed–Series A
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Tohoku Innovation Capital Corporation
MiyagiSeed–Series A
2 people
CDIB Capital
Hong KongSeries A–Series C
IBK Capital
SeoulSeed–Series B
EISAI CO.,LTD
TokyoSeed–Growth
1 person
Hermes-Epitek
HsinchuSeed
1 person
Shanghai STVC Group
ShanghaiSeed–Growth
1 person
Venture Labo Investment
TokyoSeed–Series A
Dooghoon Investment Co.
SeoulSeed–Series A
1 person
Related lists
Investors & VC Firms in North America (13321)Investors & VC Firms in United States (12313)Investors & VC Firms in Europe (6087)AI & Machine Learning Investors & VC Firms (5355)Investors & VC Firms in Global (5320)Fintech Investors & VC Firms (5141)Healthtech Investors & VC Firms (4658)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4426)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.
